Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

FORWARD PHARMA A/S

(FWP)
Delayed Nasdaq  -  02:39 2022-12-06 pm EST
3.190 USD   +13.52%
12/06Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European Patent Office in the EP2801355 Petition for Review
AQ
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/21Forward Pharma A/s : Amended and Restated Articles of Association, dated November 9, 2022 - Form 6-K
PU
SummaryQuotesChartsNewsCalendarCompanyFinancialsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

European ADRs Drop Sharply in Tuesday Trading

09/13/2022 | 11:03am EST


ę MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC -2.23% 1.75 Delayed Quote.-52.27%
AVADEL PHARMACEUTICALS PLC 1.68% 8.49 Delayed Quote.8.29%
CREDIT SUISSE GROUP AG -3.55% 2.851 Delayed Quote.-64.80%
DBV TECHNOLOGIES 0.16% 2.582 Real-time Quote.-15.72%
FORWARD PHARMA A/S 13.52% 3.19 Delayed Quote.-46.57%
MATERIALISE NV 0.56% 9.035 Delayed Quote.-62.30%
MEREO BIOPHARMA GROUP PLC 6.20% 0.875099 Delayed Quote.-48.50%
NUCANA PLC 1.88% 0.8013 Delayed Quote.-66.95%
SEQUANS COMMUNICATIONS S.A. -5.45% 3.47 Delayed Quote.-21.31%
TRINITY BIOTECH PLC 2.38% 1.29 Delayed Quote.-11.89%
VERONA PHARMA PLC -7.77% 12.2161 Delayed Quote.97.32%
ZEALAND PHARMA A/S 3.30% 203.2 Delayed Quote.35.56%
All news about FORWARD PHARMA A/S
12/06Forward Pharma Announces the Decision of the Enlarged Board of Appeal of the European P..
AQ
11/30European Equities Nudge Higher on Slightly Lower Euro Area Inflation
MT
11/21Forward Pharma A/s : Amended and Restated Articles of Association, dated November 9, 2022 ..
PU
11/21Rising COVID Cases in China, Plunging Oil Prices Drag European Equities Lower in Monday..
MT
11/15European Markets Move Higher Helped by Upbeat US Inflation Data
MT
11/14European ADRs Continue to Trend Higher in Monday Trading
MT
11/10European ADRs Surge Higher as Global Markets React to US Inflation Data
MT
11/09Forward Pharma A/S Reports Earnings Results for the Half Year Ended June 30, 2022
CI
11/08European ADRs Move Higher in Tuesday Trading, Adding to Monday's Gains
MT
10/31European ADRs Move Lower in Monday Trading
MT
More news
Financials (USD)
Sales 2021 - - -
Net income 2021 -1,89 M - -
Net cash 2021 70,8 M - -
P/E ratio 2021 -22,0x
Yield 2021 -
Capitalization 22,6 M 22,6 M -
EV / Sales 2020 -
EV / Sales 2021 -
Nbr of Employees 4
Free-Float 6,85%
Chart FORWARD PHARMA A/S
Duration : Period :
Forward Pharma A/S Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FORWARD PHARMA A/S
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Managers and Directors
Claus Bo Svendsen CEO & Principal Financial Officer
Florian Sch÷nharting Director
Grant Hellier Lawrence Independent Director
Duncan Charles Mcnaught Moore Independent Director
Torsten RŘdiger Goesch Director
Sector and Competitors
1st jan.Capi. (M$)
FORWARD PHARMA A/S-46.57%23
VERTEX PHARMACEUTICALS44.63%80 039
REGENERON PHARMACEUTICALS, INC.19.62%79 831
BIONTECH SE-37.31%39 277
WUXI APPTEC CO., LTD.-34.04%32 589
GENMAB A/S23.38%29 957